An in vitro system measuring progesterone release from silicone matrixes into serum is described. Drug release followed a matrix-controlled diffusion model in which the cumulative quantity released was linear with the square root of time. A bovine intravaginal device, consisting of a steel coil coated on both sides with a progesterone silicone matrix, was used as an in vivo drug delivery system. In vivo drug release also was matrix controlled, with rates comparable to those obtained in vitro. However, lag times of 1.7 and 4.2 days before reaching the steady-state rate were obtained for the outer and inner surfaces, respectively. The combination of effects resulted in a pseudo-zero-order drug-releasing device in which cumulative drug released was linear with time for at least 16 days.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jps.2600660619 | DOI Listing |
BJU Int
March 2025
Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.
Background: Exercise-induced urinary incontinence (UI) can hinder physical activity, particularly in women engaging in high-impact activities. This condition is linked to reduced passive support of the urethra and bladder. Intravaginal devices that support pelvic structures may offer a solution, but high-quality evidence is lacking.
View Article and Find Full Text PDFGates Open Res
March 2025
Médecins Sans Frontières, Harare, Zimbabwe.
Background: Expanding contraceptive options could better meet users' diverse needs and preferences. Annovera is a contraceptive vaginal ring that provides a year of pregnancy prevention while remaining under user control and allowing for regular menstrual cycles. This method may also help to reduce burdens on some health care and supply chain systems.
View Article and Find Full Text PDFNon-surgical procedures such as fillers, PRP and derivatives, energy-based devices and adipose derivate mesenchymal stem cell treatments are begun to be used in women genital area for both functional and aesthetic purposes. After theproduction of injectable HA for genital use, patients were able to benefit more effectively from these applications and its use in the vagina became more common. In our study, we aimed to demonstrate a new intravaginal injection technique, Cannulated Intravaginal Injection Technique (CIVIT) that we can perform vaginal injection more homogenously and less traumatic and more effectively to the entire vaginal mucosa.
View Article and Find Full Text PDFReprod Domest Anim
March 2025
Faculdade de Veterinária, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
The study aimed to evaluate the effects of GnRH given 34 h after progesterone (P4) intravaginal device (IVD) removal in a timed artificial insemination (TAI) protocol. In Experiment 1, 17 Hereford and Braford heifers (control, n = 7; GnRH34; n = 10) received 2 mg estradiol benzoate (EB) and a 1 g P4 IVD on Day 0 (D0). On D8, IVDs were removed and 150 μg d-cloprostenol (PGF) and 1 mg estradiol cypionate (EC) were administered.
View Article and Find Full Text PDFReprod Domest Anim
March 2025
Department of Veterinary Surgery and Animal Reproduction, São Paulo State University (Unesp), School of Veterinary Medicine and Animal Science, Botucatu, Brazil.
This study evaluated the effect of equine chorionic gonadotropin (eCG) on ovarian vascularisation and plasma progesterone (P4) levels in Murrah buffaloes during an ovulation synchronisation protocol. Twenty buffaloes were divided into two groups: with eCG (n = 20) and without eCG (control, n = 20) in a crossover design. A 1.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!